Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

SpaceX, OpenAI and Anthropic Set the Stage for an IPO Frenzy

Jim Neesen of Connor Group discusses the AI-driven IPO boom, SpaceX, OpenAI, Anthropic and whether Wall Street can sustain the hype.

Why the Beijing Summit Could Reshape the Future of AI

Politico’s Aaron Mak breaks down the Trump-Xi Beijing summit, AI competition, semiconductor tensions and what it means for global tech.

Inside the Clarity Act: Can Washington Finally Bring Order to Crypto?

The Clarity Act could reshape U.S. crypto regulation by defining digital assets and resolving SEC–CFTC jurisdiction. Paul Grewal of Coinbase weighs in.

From Whoppers to Worldwide Buzz: Burger King’s Next Act

Tom Curtis, President of Burger King U.S. & Canada, discusses growth strategy, earnings momentum and partnership with The Mandalorian and Grogu.

The Hidden Risk of AI Adoption? Appian CEO Matt Calkins Breaks It Down

Matt Calkins, CEO of Appian, discusses earnings, the AI boom, outdated enterprise software, and rising security risks.

Inside the Space Tech Firm Powering America’s Return to the Moon

Chris Edmunds, CFO of Redwire, discusses NASA missions, ISS innovation, space pharma, and the company’s rapid 2026 growth.

Big Business This Week: ‘They’re Getting Their Money Back’ — A Trade Lawyer on the Tariff Collapse

We spoke with a lawyer who sued the federal government on behalf of 100 companies over the emergency tariffs.

Why HealthCentral Is Betting Big on an App to Fix Medical Misinformation

HealthCentral CEO Justin Chase joins to discuss the drops app and its mission to combat medical misinformation and improve access to trusted health info.

Why Wall Street Is Betting Big on Cerebras

Cerebras CMO Julie Choi joins live from the NASDAQ to break down the company’s blockbuster IPO and AI ambitions.

Why Ouster’s New Color LiDAR Could Change Robotics Forever

Ouster CEO Angus Pacala explains how next-gen LiDAR and physical AI are transforming robotics, automation, and autonomy.

Load More